Upgrade to SI Premium - Free Trial

UiPath Inc. (PATH) PT Lowered to $15 at Canaccord

March 12, 2026 6:53 AM
Canaccord analyst Kingsley Cran lowered the price target on UiPath Inc. (NYSE: PATH) to $15.00 (from $19.00) while maintaining a Buy rating.

Categories

Analyst PT Change